SCHEMBL4849339

SCHEMBL4849339

CCOC(=O)c1cn(C(=O)OC(C)(C)C)nc1OCOC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
GAA P10253 3/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TSHR P16473 1/20 0.35
GLA P06280 2/20 0.34
CSNK1D P48730 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16635020 0.89 ALDH1A1 (0.41) CRHBPCRHR2ALDH1A1KDM4EHPGD
SCHEMBL20239906 0.84 CRHBP (0.38) CRHBPCRHR2ALDH1A1KDM4EHPGD
SCHEMBL22735722 0.82 CRHBP (0.36) CRHBPCRHR2ALDH1A1KDM4EHPGD
SCHEMBL23009907 0.81 MEN1 (0.42) CRHBPCRHR2ALDH1A1KDM4EHPGD
SCHEMBL4852951 0.81 CRHBP (0.44) CRHBPCRHR2ALDH1A1KDM4EHPGD
SCHEMBL8694142 0.80 ALDH1A1 (0.40) CRHBPCRHR2ALDH1A1KDM4EHPGD
SCHEMBL23009971 0.80 MEN1 (0.39) CRHBPCRHR2ALDH1A1KDM4EHPGD
SCHEMBL20029632 0.80 MEN1 (0.35) CRHBPCRHR2ALDH1A1KDM4EHPGD
SCHEMBL21441965 0.79 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL29139295 0.78 CRHBP (0.35) CRHBPCRHR2ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368578-B2 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-06 US disclosed
US-20060135578-A1 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-06-22 US disclosed
EP-1541564-A1 FIVE-MEMBERED HETEROCYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135578-A1 Five-membered heterocyclic compounds GPR119, OR10J3, CYP11B1 CRHBP 3960/4885CRHR2 2744/4885ALDH1A1 821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.